Cargando…

Beam Output Audit results within the EORTC Radiation Oncology Group network

Beam Output Auditing (BOA) is one key process of the EORTC radiation therapy quality assurance program. Here the results obtained between 2005 and 2014 are presented and compared to previous results. For all BOA reports the following parameters were scored: centre, country, date of audit, beam energ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurkmans, Coen W., Christiaens, Melissa, Collette, Sandra, Weber, Damien Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159966/
https://www.ncbi.nlm.nih.gov/pubmed/27978843
http://dx.doi.org/10.1186/s13014-016-0733-4
_version_ 1782481851839938560
author Hurkmans, Coen W.
Christiaens, Melissa
Collette, Sandra
Weber, Damien Charles
author_facet Hurkmans, Coen W.
Christiaens, Melissa
Collette, Sandra
Weber, Damien Charles
author_sort Hurkmans, Coen W.
collection PubMed
description Beam Output Auditing (BOA) is one key process of the EORTC radiation therapy quality assurance program. Here the results obtained between 2005 and 2014 are presented and compared to previous results. For all BOA reports the following parameters were scored: centre, country, date of audit, beam energies and treatment machines audited, auditing organisation, percentage of agreement between stated and measured dose. Four-hundred and sixty-one BOA reports were analyzed containing the results of 1790 photon and 1366 electron beams, delivered by 755 different treatment machines. The majority of beams (91.1%) were within the optimal limit of ≤ 3%. Only 13 beams (0.4%; n = 9 electrons; n = 4 photons), were out of the range of acceptance of ≤ 5%. Previous reviews reported a much higher percentage of 2.5% or more of the BOAs with >5% deviation. The majority of EORTC centres present beam output variations within the 3% tolerance cutoff value and only 0.4% of audited beams presented with variations of more than 5%. This is an important improvement compared to previous BOA results.
format Online
Article
Text
id pubmed-5159966
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51599662016-12-23 Beam Output Audit results within the EORTC Radiation Oncology Group network Hurkmans, Coen W. Christiaens, Melissa Collette, Sandra Weber, Damien Charles Radiat Oncol Short Report Beam Output Auditing (BOA) is one key process of the EORTC radiation therapy quality assurance program. Here the results obtained between 2005 and 2014 are presented and compared to previous results. For all BOA reports the following parameters were scored: centre, country, date of audit, beam energies and treatment machines audited, auditing organisation, percentage of agreement between stated and measured dose. Four-hundred and sixty-one BOA reports were analyzed containing the results of 1790 photon and 1366 electron beams, delivered by 755 different treatment machines. The majority of beams (91.1%) were within the optimal limit of ≤ 3%. Only 13 beams (0.4%; n = 9 electrons; n = 4 photons), were out of the range of acceptance of ≤ 5%. Previous reviews reported a much higher percentage of 2.5% or more of the BOAs with >5% deviation. The majority of EORTC centres present beam output variations within the 3% tolerance cutoff value and only 0.4% of audited beams presented with variations of more than 5%. This is an important improvement compared to previous BOA results. BioMed Central 2016-12-15 /pmc/articles/PMC5159966/ /pubmed/27978843 http://dx.doi.org/10.1186/s13014-016-0733-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Hurkmans, Coen W.
Christiaens, Melissa
Collette, Sandra
Weber, Damien Charles
Beam Output Audit results within the EORTC Radiation Oncology Group network
title Beam Output Audit results within the EORTC Radiation Oncology Group network
title_full Beam Output Audit results within the EORTC Radiation Oncology Group network
title_fullStr Beam Output Audit results within the EORTC Radiation Oncology Group network
title_full_unstemmed Beam Output Audit results within the EORTC Radiation Oncology Group network
title_short Beam Output Audit results within the EORTC Radiation Oncology Group network
title_sort beam output audit results within the eortc radiation oncology group network
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159966/
https://www.ncbi.nlm.nih.gov/pubmed/27978843
http://dx.doi.org/10.1186/s13014-016-0733-4
work_keys_str_mv AT hurkmanscoenw beamoutputauditresultswithintheeortcradiationoncologygroupnetwork
AT christiaensmelissa beamoutputauditresultswithintheeortcradiationoncologygroupnetwork
AT collettesandra beamoutputauditresultswithintheeortcradiationoncologygroupnetwork
AT weberdamiencharles beamoutputauditresultswithintheeortcradiationoncologygroupnetwork